Biovica’s analysis of clinical data suggests that TKa has high potential for monitoring HR+ MBC.
Breast cancer in post-menopausal women come with unique physical and emotional challenges. Learn more here.
Discover the benefits of biomarker testing for healthcare providers and patients. Read more here.
Thymidine kinase 1 can be used as a biomarker to monitor metastatic breast cancer treatment. Learn more.
TK1 activity testing can be integrated into clinical research to improve breast cancer treatment outcomes. Click here to read more.
Thymidine kinase 1 plays a key role in cell proliferation, and TKa testing can aid in monitoring breast cancer progression. ...
Blood-based biomarkers play a key role in biopharma applications, from disease monitoring to treatment development. Learn more.
Discover the key biomarkers associated with breast cancer, such as HER2, Ki-67, thymidine kinase, and more. Read now.
Blood-based biomarkers are measurable indicators that can provide information on a person’s health and disease treatment response. Read ...
Discover the signs and symptoms of breast cancer and the benefits of early detection. Read more.